Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rev (REVG) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Rev (REVG) over the last 10 years, with Q4 2025 value amounting to $34.7 million.

  • Rev's Cash & Equivalents rose 4105.69% to $34.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $34.7 million, marking a year-over-year increase of 4105.69%. This contributed to the annual value of $34.7 million for FY2025, which is 4105.69% up from last year.
  • Per Rev's latest filing, its Cash & Equivalents stood at $34.7 million for Q4 2025, which was up 4105.69% from $36.0 million recorded in Q3 2025.
  • Rev's Cash & Equivalents' 5-year high stood at $87.9 million during Q1 2024, with a 5-year trough of $5.9 million in Q2 2022.
  • Moreover, its 5-year median value for Cash & Equivalents was $20.8 million (2022), whereas its average is $24.5 million.
  • In the last 5 years, Rev's Cash & Equivalents plummeted by 8647.85% in 2021 and then surged by 35909.09% in 2024.
  • Rev's Cash & Equivalents (Quarter) stood at $13.3 million in 2021, then surged by 53.38% to $20.4 million in 2022, then rose by 4.41% to $21.3 million in 2023, then rose by 15.49% to $24.6 million in 2024, then surged by 41.06% to $34.7 million in 2025.
  • Its Cash & Equivalents stands at $34.7 million for Q4 2025, versus $36.0 million for Q3 2025 and $28.8 million for Q2 2025.